BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cleminorexton readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Cleminorexton\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07598708-11231@assetmemo.bio
DTSTAMP:20261121T004543Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Cleminorexton: Phase 2/3 readout est. (NCT07598708)
DESCRIPTION:Cleminorexton\, phase 2/3\, Narcolepsy.\nStudy: A Study to Inve
 stigate the Effects of Cleminorexton Compared With Placebo in the Treatmen
 t of Participants With Central Disorders of Hypersomnolence\nEstimated pri
 mary completion: 30 September 2027. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/cleminorexton#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07598708
URL:https://assetmemo.bio/drug/cleminorexton#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
